REAL-WORLD TREATMENT PATTERNS, HEALTHCARE RESOURCE UTILIZATION (HCRU) AND CLINICAL OUTCOMES OF PATIENTS WITH EXTENSIVE-STAGE SMALL-CELL LUNG CANCER (ES-SCLC) IN ALBERTA, CANADA

被引：0
|
作者：
Suri, G. [1 ]
Boyne, D. J. [2 ]
Caveen, M. [3 ]
Mak, D. [3 ]
Takundwa, R. [4 ]
Wani, R. J. [3 ]
Cheung, W. [2 ]
机构：
[1] Amgen Ltd, Uxbridge, England
[2] Oncol Outcomes, Calgary, AB, Canada
[3] Amgen Canada Inc, Mississauga, ON, Canada
[4] Amgen Ltd, Uxbridge, England
来源：
VALUE IN HEALTH | 2024年 / 27卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
CO37
引用
收藏
页码：S23 / S23
页数：1
相关论文
共 50 条
  • [41] Phase I study of ramucirumab in combination with irinotecan plus cisplatin in patients (pts) with extensive-stage small cell lung cancer (ES-SCLC)
    Takahashi, T.
    Mori, K.
    Mizuno, R.
    Mamesaya, N.
    Kobayashi, H.
    Omori, S.
    Wakuda, K.
    Ono, A.
    Naito, T.
    Murakami, H.
    Kenmotsu, H.
    ANNALS OF ONCOLOGY, 2021, 32 : S1165 - S1165
  • [42] Continuing immune checkpoint inhibitors after progression: Real-world patterns of care and outcomes in second-line treatment for extensive-stage small-cell lung cancer
    Zhang, Baishen
    Bao, Hejing
    Li, Zhanquan
    Chen, Jing
    Yu, Hui
    Li, Meichen
    Cai, Muyan
    Chen, Likun
    LUNG CANCER, 2025, 199
  • [43] Clinical outcomes and synergistic effect between radiotherapy and immunotherapy in patients with extensive-stage small cell lung cancer: a real-world study
    Sun, Meiling
    Ji, Huaijun
    Deng, Fang
    Li, Jingyi
    Xu, Ning
    Li, Yu
    BMC CANCER, 2024, 24 (01)
  • [44] Treatment (tx) characteristics and clinical outcomes in patients (pts) with extensive-stage small cell lung cancer (ES-SCLC) treated with carboplatin (carbo) or cisplatin (cis) in combination with etoposide (etop) in US clinical practice
    Sebastian, M.
    Barlesi, F.
    Califano, R.
    Mansfield, A. S.
    Blackhall, F. H.
    Flahavan, E. M.
    Davies, J.
    Arnold, P.
    Morris, S.
    Reck, M.
    ANNALS OF ONCOLOGY, 2019, 30
  • [45] The Impact of the Stage III Randomized Trial by Takahashi et al. on the Use of Prophylactic Cranial Irradiation (PCI) in Patients with Extensive-Stage Small-Cell Lung Cancer (ES-SCLC)
    Gjyshi, O.
    Ludmir, E. B.
    Dursteler, A.
    Lin, S. H.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 104 (01): : 230 - 230
  • [46] French real world study on patient characteristics and treatment strategies in first-line of extensive-stage small cell lung cancer (ES SCLC)
    Debieuvre, D.
    Dayen, C.
    Dixmier, A.
    Gally, S.
    Pau, D.
    Greenwood, W.
    Falchero, L.
    ANNALS OF ONCOLOGY, 2020, 31 : S1038 - S1038
  • [47] Real-world safety and healthcare resource utilization (HCRU) of lurbinectedin (lurbi) in patients (pts) with small cell lung cancer (SCLC): Jazz EMERGE 402 updated analysis.
    Badin, Firas Benyamine
    Lammers, Philip Edward
    Patel, Mehul P.
    Shunyakov, Leonid
    Slater, Dennis
    Labbe, Catherine
    Naveh, Navit
    Boccuti, Anne
    Hanvesakul, Raj
    Li, Wenyan
    Rengarajan, Badri
    Halmos, Balazs
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [48] Financial toxicity of front-line platinum etoposide plus atezolizumab versus durvalumab in extensive-stage small-cell (ES-SCLC) lung cancer.
    Harrison, Bradley
    Keith, Nicole
    Verbyla, Allison
    Mileham, Kathryn Finch
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (28) : 23 - 23
  • [49] Correlation between multiorgan immune-related adverse events and clinical outcomes in patients with extensive-stage small cell lung cancer (ES-SCLC) treated with chemo-immunotherapy.
    Monaca, Federico
    Rodriguez, Martin Igor Gomez-Randulfe
    Vita, Emanuele
    Cosmai, Antonia
    Polidori, Sara
    Stefani, Alessio
    Horn, Guido
    Mastrantoni, Luca
    Vitale, Antonio
    Russo, Jacopo
    Occhipinti, Denis
    Scala, Alessandro
    Troisi, Paola
    D'Argento, Ettore
    Di Salvatore, Mariantonietta
    Tortora, Giampaolo
    Califano, Raffaele
    Bria, Emilio
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [50] A retrospective real-world experience of immunotherapy in patients with extensive stage small-cell lung cancer
    Qiu, Guihuan
    Wang, Fei
    Xie, Xiaohong
    Liu, Ting
    Zeng, Chen
    Chen, Ziyao
    Zhou, Maolin
    Deng, Haiyi
    Yang, Yilin
    Lin, Xinqing
    Xie, Zhanhong
    Sun, Gengyun
    Zhou, Chengzhi
    Liu, Ming
    CANCER MEDICINE, 2023, 12 (14): : 14881 - 14891
12345